Long-Term Clinical Outcomes Following the WATCHMAN Device Use in Medicare Beneficiaries
Compared with patients enrolled in the pivotal clinical trials, Medicare beneficiaries undergoing WATCHMAN implantation were older, more female, and had more comorbid conditions. Substantial long-term mortality and major bleeding following WATCHMAN reflect the high-risk nature of the patient population, while the ischemic stroke rate was relatively low (<1.5% per year).
Authors
- Thomas Christen
- Kristine Roy
- Dominic J. Allocco (ORCID: https://orcid.org/0000-0002-0577-1555)
- Emily P. Zeitler (ORCID: https://orcid.org/0000-0002-4848-4775)
- David Jonathan Cohen (ORCID: https://orcid.org/0000-0001-9163-724X)
- Matthew R. Reynolds (ORCID: https://orcid.org/0000-0001-8675-8186)
- Robert I. Griffiths (ORCID: https://orcid.org/0000-0002-9751-8572)
- Boyang Bian (ORCID: https://orcid.org/0000-0003-0153-4218)
Institutions
- Dartmouth Institute for Health Policy and Clinical Practice (US)
- Lahey Hospital and Medical Center (US)
- Boston Scientific (United States) (US)
- St. Francis Hospital (US)
- St. Francis Hospital (US)
- Lahey Medical Center (US)
- Baim Institute for Clinical Research (US)
- Cardiovascular Research Foundation (US)
- St. Francis Hospital (US)
Publication Details
- Journal
- Circulation Cardiovascular Quality and Outcomes
- Published
- 2024-10-01
- DOI
- https://doi.org/10.1161/circoutcomes.124.011007
- Citations
- 2
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.80
Funders
- Boston Scientific Corporation